期刊文献+

阿尔茨海默病患者血清补体C5a水平及其与炎症因子的相关性 被引量:6

Serum complement C5a levels and its association with inflammatory factors in patients with Alzheimer’s disease
原文传递
导出
摘要 目的探讨阿尔茨海默病(Alzheimer’s disease,AD)患者血清补体C5a水平及其与炎症因子的相关性,阐明其临床意义。方法选择杭州市第七人民医院2018年1月-2018年12月的AD患者110例作为AD组,同期健康体检者110例作为对照组。测定血清C5a水平及血清高敏C-反应蛋白(high sensitive C-reaction protein,hs-CRP)、白细胞介素1β(interleukin-1β,IL-1β)、IL-6、肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)水平。结果AD组简易精神状态量表(simple mental state scale,MMSE)评分[(15.62±3.21)分]低于对照组[(29.34±3.82)分],t=28.839,P<0.05,C5a水平[(73.51±9.42)pg/mL]高于对照组[(64.29±9.34)pg/mL],t=7.290,P<0.05。AD组血清hs-CRP、IL-1β、IL-6、TNF-α水平[(5.03±0.60)pg/mL、(37.49±7.46)pg/mL、(105.34±13.13)pg/mL、(196.54±12.06)pg/mL]高于对照组(t=45.395、9.939、25.704、7.086,均P<0.05)。AD患者血清C5a、hs-CRP、IL-1β、IL-6、TNF-α水平与MMSE评分均呈负相关(r=-0.421、-0.523、-0.436、-0.445、-0.507,均P<0.05)。AD患者血清C5a与血清hs-CRP、IL-1β、IL-6、TNF-α水平均呈正相关(r=0.564、0.602、0.641、0.539,均P<0.05)。结论AD患者血清补体C5a水平升高,C5a水平与AD患者认知功能和血清炎症因子水平关系密切。 Objective To investigate the serum complement C5 a level and its relationship with inflammatory factors in patients with Alzheimer’s disease(AD)in order to elucidate its clinical significance.Methods Total 110 patients with AD in Hangzhou Seventh People’s Hospital from January to December 2018 were selected as AD group,and 110 healthy subjects were selected as control group.The serum C5 a level,high sensitive C-reaction protein(hs-CRP),interleukin-1β(IL-1β),IL-6 and tumor necrosis factor-α(TNF-α)levels were measured.Results The score of the simple mental state scale(MMSE)of the AD group[(15.62±3.21)scores]was lower than that of the control group[(29.34±3.82)scores,t=28.839,P<0.05],and the level of C5 a[(73.51±9.42)pg/mL]was higher than that of the control group[(64.29±9.34)pg/mL,t=7.290,P<0.05].The levels of serum hs-CRP,IL-1β,IL-6 and TNF-αin the AD group[(5.03±0.60)pg/mL,(37.49±7.46)pg/mL,(105.34±13.13)pg/mL,(196.54±12.06)pg/mL]were higher than those in the control group(t=45.395,9.939,25.704,7.086,all P<0.05).The levels of serum C5 a,hs-CRP,IL-1β,IL-6 and TNF-αin AD patients were negatively correlated with MMSE scores(r=-0.421,-0.523,-0.436,-0.445,-0.507,all P<0.05).The serum C5 a was positively correlated with serum hs-CRP,IL-1β,IL-6 and TNF-αlevels in AD patients(r=0.564,0.602,0.641,0.539,all P<0.05).Conclusion Serum complement C5 a level is elevated in patients with AD,and it is closely related to cognitive function and serum inflammatory factor levels in AD patients.
作者 胡晨玲 张学平 杨荣梅 周芬芳 HU Chen-ling;ZHANG Xue-ping;YANG Rong-mei;ZHOU Fen-fang(The Third Ward of Department of Geriatrics,the Seventh People's Hospital of Hangzhou,Hangzhou,Zhejiang 310013,China;不详)
出处 《中华全科医学》 2020年第5期760-762,共3页 Chinese Journal of General Practice
基金 浙江省医药卫生科技计划项目(2018KY610)。
关键词 阿尔茨海默病 C5A 细胞因子 认知功能 Alzheimer’s disease C5a Cytokines Cognitive function
  • 相关文献

参考文献3

二级参考文献33

  • 1McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer' s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer' s Disease. Neurology, 1984, 34:939-944.
  • 2Knopman DS, DeKosky ST, Cummings JL, et al. Practice parameter: Diagnosis of dementia (an evidence-based review). Neurology, 2001, 56 : 1143-I 153.
  • 3Jack CRJ, Albert M, Knopman DS, et al. Introduction to revised criteria for the diagnosis of Alzheimer' s disease : National Institute on Aging and the Alzheimer Association Workgroups. Alzheimers Dement, 2011,7 :in press.
  • 4Sperling RA, Aisen P, Beckett L, et al. Towards defining the preclinical stage of Alzheimer' s disease: recommendations from the National Institute on Aging and the Alzbeimer' s Association Workgroup. Alzheimers Dement, 2011,7:280-292.
  • 5Albert M, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer' s disease: Report of the National Institute on Aging and the Alzheimer' s Association Workgroup. Alzheimers Dement, 2011,7 : in press.
  • 6Jack CR, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer' s pathological cascade. Lancet Neurol, 2010, 9 : 119-128.
  • 7Fagan AM, Head D, Shah AR, et al. Decreased cerebrospinal fluid Abeta (42) correlates with brain atrophy in cognitively normal elderly. Ann Neurol, 2009, 65:176-183.
  • 8McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology, 2005, 65:1863-1872.
  • 9Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology, 1993, 43: 250-260.
  • 10Rascovsky K, Hodges JR, Kipps CM, et al. Diagnostic Criteria for the Behavioral Variant of Frontotemporal Dementia (bvFTD) : Current Limitations and Future Directions. Alzheimer Dis AssocDisord, 2007, 21 :S14-18.

共引文献78

同被引文献72

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部